These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 34995493)

  • 1. Down-syndrome-induced senescence disrupts the nuclear architecture of neural progenitors.
    Meharena HS; Marco A; Dileep V; Lockshin ER; Akatsu GY; Mullahoo J; Watson LA; Ko T; Guerin LN; Abdurrob F; Rengarajan S; Papanastasiou M; Jaffe JD; Tsai LH
    Cell Stem Cell; 2022 Jan; 29(1):116-130.e7. PubMed ID: 34995493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human iPSC-derived Down syndrome astrocytes display genome-wide perturbations in gene expression, an altered adhesion profile, and increased cellular dynamics.
    Ponroy Bally B; Farmer WT; Jones EV; Jessa S; Kacerovsky JB; Mayran A; Peng H; Lefebvre JL; Drouin J; Hayer A; Ernst C; Murai KK
    Hum Mol Genet; 2020 Mar; 29(5):785-802. PubMed ID: 31943018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of Integration-Free Induced Pluripotent Stem Cells from Urine-Derived Cells Isolated from Individuals with Down Syndrome.
    M Lee Y; Zampieri BL; Scott-McKean JJ; Johnson MW; Costa ACS
    Stem Cells Transl Med; 2017 Jun; 6(6):1465-1476. PubMed ID: 28371411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptome and Proteome Profiling of Neural Induced Pluripotent Stem Cells from Individuals with Down Syndrome Disclose Dynamic Dysregulations of Key Pathways and Cellular Functions.
    Sobol M; Klar J; Laan L; Shahsavani M; Schuster J; Annerén G; Konzer A; Mi J; Bergquist J; Nordlund J; Hoeber J; Huss M; Falk A; Dahl N
    Mol Neurobiol; 2019 Oct; 56(10):7113-7127. PubMed ID: 30989628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA methylation changes in Down syndrome derived neural iPSCs uncover co-dysregulation of ZNF and HOX3 families of transcription factors.
    Laan L; Klar J; Sobol M; Hoeber J; Shahsavani M; Kele M; Fatima A; Zakaria M; Annerén G; Falk A; Schuster J; Dahl N
    Clin Epigenetics; 2020 Jan; 12(1):9. PubMed ID: 31915063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modeling neurogenesis impairment in Down syndrome with induced pluripotent stem cells from Trisomy 21 amniotic fluid cells.
    Lu HE; Yang YC; Chen SM; Su HL; Huang PC; Tsai MS; Wang TH; Tseng CP; Hwang SM
    Exp Cell Res; 2013 Feb; 319(4):498-505. PubMed ID: 23041301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isogenic pairs of induced-pluripotent stem-derived endothelial cells identify DYRK1A/PPARG/EGR1 pathway is responsible for Down syndrome-associated pulmonary hypertension.
    Suginobe H; Ishida H; Ishii Y; Ueda K; Yoshihara C; Ueyama A; Wang R; Tsuru H; Hashimoto K; Hirose M; Ishii R; Narita J; Kitabatake Y; Ozono K
    Hum Mol Genet; 2023 Dec; 33(1):78-90. PubMed ID: 37792788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. iPSC-derived progenitor stromal cells provide new insights into aberrant musculoskeletal development and resistance to cancer in down syndrome.
    Galat Y; Perepitchka M; Elcheva I; Iannaccone S; Iannaccone PM; Galat V
    Sci Rep; 2020 Aug; 10(1):13252. PubMed ID: 32764607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brief report: isogenic induced pluripotent stem cell lines from an adult with mosaic down syndrome model accelerated neuronal ageing and neurodegeneration.
    Murray A; Letourneau A; Canzonetta C; Stathaki E; Gimelli S; Sloan-Bena F; Abrehart R; Goh P; Lim S; Baldo C; Dagna-Bricarelli F; Hannan S; Mortensen M; Ballard D; Syndercombe Court D; Fusaki N; Hasegawa M; Smart TG; Bishop C; Antonarakis SE; Groet J; Nizetic D
    Stem Cells; 2015 Jun; 33(6):2077-84. PubMed ID: 25694335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcriptomes of Dravet syndrome iPSC derived GABAergic cells reveal dysregulated pathways for chromatin remodeling and neurodevelopment.
    Schuster J; Laan L; Klar J; Jin Z; Huss M; Korol S; Noraddin FH; Sobol M; Birnir B; Dahl N
    Neurobiol Dis; 2019 Dec; 132():104583. PubMed ID: 31445158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A dynamic in vitro model of Down syndrome neurogenesis with trisomy 21 gene dosage correction.
    Bansal P; Banda EC; Glatt-Deeley HR; Stoddard CE; Linsley JW; Arora N; Deleschaux C; Ahern DT; Kondaveeti Y; Massey RE; Nicouleau M; Wang S; Sabariego-Navarro M; Dierssen M; Finkbeiner S; Pinter SF
    Sci Adv; 2024 Jun; 10(23):eadj0385. PubMed ID: 38848354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptome analysis of genetically matched human induced pluripotent stem cells disomic or trisomic for chromosome 21.
    Gonzales PK; Roberts CM; Fonte V; Jacobsen C; Stein GH; Link CD
    PLoS One; 2018; 13(3):e0194581. PubMed ID: 29584757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TSC patient-derived isogenic neural progenitor cells reveal altered early neurodevelopmental phenotypes and rapamycin-induced MNK-eIF4E signaling.
    Martin P; Wagh V; Reis SA; Erdin S; Beauchamp RL; Shaikh G; Talkowski M; Thiele E; Sheridan SD; Haggarty SJ; Ramesh V
    Mol Autism; 2020; 11(1):2. PubMed ID: 31921404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of two induced pluripotent stem cell lines from patients with Down syndrome.
    Zhu W; Liu W; Yu R; Manning M; Waran Romfh A; Wu JC
    Stem Cell Res; 2023 Oct; 72():103204. PubMed ID: 37734318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. OLIG2 Drives Abnormal Neurodevelopmental Phenotypes in Human iPSC-Based Organoid and Chimeric Mouse Models of Down Syndrome.
    Xu R; Brawner AT; Li S; Liu JJ; Kim H; Xue H; Pang ZP; Kim WY; Hart RP; Liu Y; Jiang P
    Cell Stem Cell; 2019 Jun; 24(6):908-926.e8. PubMed ID: 31130512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modelling and rescuing neurodevelopmental defect of Down syndrome using induced pluripotent stem cells from monozygotic twins discordant for trisomy 21.
    Hibaoui Y; Grad I; Letourneau A; Sailani MR; Dahoun S; Santoni FA; Gimelli S; Guipponi M; Pelte MF; Béna F; Antonarakis SE; Feki A
    EMBO Mol Med; 2014 Feb; 6(2):259-77. PubMed ID: 24375627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Migration deficits of the neural crest caused by CXADR triplication in a human Down syndrome stem cell model.
    Liu H; Huang S; Wang W; Wang H; Huang W; Zhai Z; Wang D; Fan Y; Sun J; Li D; Chiu W; Lai X; Zeng J; Ke Q; Wang T; Xiang AP; Yuan Y; Zhang X; Li W
    Cell Death Dis; 2022 Dec; 13(12):1018. PubMed ID: 36470861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integration-free induced pluripotent stem cells model genetic and neural developmental features of down syndrome etiology.
    Briggs JA; Sun J; Shepherd J; Ovchinnikov DA; Chung TL; Nayler SP; Kao LP; Morrow CA; Thakar NY; Soo SY; Peura T; Grimmond S; Wolvetang EJ
    Stem Cells; 2013 Mar; 31(3):467-78. PubMed ID: 23225669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of two human iPSC lines (UUIGPi013-A and UUIPGi014-A) from cases with Down syndrome and full trisomy for chromosome 21 (T21).
    Schuster J; Hoeber J; Sobol M; Fatima A; Annerén G; Dahl N
    Stem Cell Res; 2020 Dec; 49():102081. PubMed ID: 33220594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcriptome analysis of MBD5-associated neurodevelopmental disorder (MAND) neural progenitor cells reveals dysregulation of autism-associated genes.
    Mullegama SV; Klein SD; Williams SR; Innis JW; Probst FJ; Haldeman-Englert C; Martinez-Agosto JA; Yang Y; Tian Y; Elsea SH; Ezashi T
    Sci Rep; 2021 May; 11(1):11295. PubMed ID: 34050248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.